文献速递临床试验与 GCP

预先球囊瓣膜成形术对比直接经导管主动脉瓣植入术(DIRECTAVI):一项随机对照试验的研究方案

Prior balloon valvuloplasty versus DIRECT transcatheter Aortic Valve Implantation (DIRECTAVI): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-07-04

DIRECTAVI试验为随机对照开放标签研究,纳入240例有TAVI指征的患者,随机分为预先球囊瓣膜成形术组(对照组)或直接植入瓣膜组(试验组)。试验检验使用新一代球囊扩张式SAPIEN 3瓣膜直接植入的策略不劣于现行预先扩张瓣膜的医疗实践。主要终点为即刻手术成功,次要终点为30天随访并发症(VARC-2标准)。

要点

  • 直接植入组使用新一代球囊扩张式SAPIEN 3瓣膜,对照组为预先球囊瓣膜成形术。
  • 主要终点为评估手术疗效与安全性的即刻手术成功。
  • 亚组分析用脑MRI评估每组25例患者的神经缺血事件。

核心结论

  • 试验检验直接植入新一代球囊扩张式SAPIEN 3瓣膜不劣于现行预先球囊瓣膜成形术的医疗实践。
  • 研究旨在提供该策略优势的可靠证据,以便介入心脏病学家在日常实践中使用。

研究设计与样本

  • 随机对照开放标签试验,纳入240例有TAVI指征的患者,排除需要经心尖途径者。
  • 随机分为TAVI预先球囊瓣膜成形术组(对照组)或直接植入瓣膜组(试验组)。

主要发现

  • 主要终点为评估手术疗效与安全性的即刻手术成功。
  • 次要终点包括30天随访并发症(VARC-2标准)。
  • 亚组分析每组25例患者,在术前及术后1至3天行脑MRI评估神经缺血事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Balloon predilatation of the aortic valve has been regarded as an essential step during the transcatheter aortic valve implantation (TAVI) procedure. However, recent evidence has suggested that aortic valvuloplasty may cause complications and that high success rates may be obtained without prior dilatation of the valve. We hypothesize that TAVI performed without predilatation of the aortic valve and using new-generation balloon-expandable transcatheter heart valves is associated with a better net clinical benefit than TAVI performed with predilatation. METHODS/DESIGN: The transcatheter aortic valve implantation without prior balloon dilatation (DIRECTAVI) trial is a randomized controlled open label trial that includes 240 patients randomized to TAVI performed with prior balloon valvuloplasty (control arm) or direct implantation of the valve (test arm). All patients with an indication for TAVI will be included excepting those requiring transapical access. The trial tests the hypothesis that the strategy of direct implantation of the new-generation balloon-expandable SAPIEN 3 valve is noninferior to current medical practice using predilatation of the valve. The primary endpoint assessing efficacy and safety of the procedure consists of immediate procedural success and secondary endpoints include complications at 30-day follow-up (VARC-2 criteria). A subgroup analysis evaluates neurological ischemic events with cerebral MRI imaging (25 patients in each strategy group) performed before and between 1 and 3 days after the procedure. DISCUSSION: This prospective randomized study is designed to assess the efficacy and safety of TAVI performed without prior dilatation of the aortic valve using new-generation balloon-expandable transcatheter heart valves. We aim to provide robust evidence of the advantages of this strategy to allow the interventional cardiologist to use it in everyday practice. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02729519 . Registered on 15 July 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Leclercq F, Robert P, Labour J, et al. Prior balloon valvuloplasty versus DIRECT transcatheter Aortic Valve Implantation (DIRECTAVI): study protocol for a randomized controlled trial. Trials. 2017. PMID: 28676065. doi:10.1186/s13063-017-2036-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。